Clinical trial of transjugular intrahepatic portosystemic shunt(TIPS) combined with variceal embolization in the prevention of rebleeding in cirrhotic patients.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11000192

Enrollment

Unknown

Registered

2011-01-26

Start date

2007-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic cirrhosis, esophageal variceal bleeding

Interventions

TIPS+ embolization:Receive treatments of TIPS and variceal embolization

TIPS:Receive only TIPS

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Older than 18 years; (2) Confirmed diagnosis of hepatic cirrhosis; (3) Endoscopic evidence of esophageal variceal bleeding; (4) Agreed to participate in the trial, and assigned informed consent.

Exclusion criteria

Exclusion criteria: (1) Younger than 18 years or older than 75 years; (2) Pregnant and breeding women; (3) Previous episode(s) of chronic recurrent hepatic encephalopathy; (4) Severe disorders of other vital organs, such as heart, lung, kidney; (5) severe cogulation difficiency; (6) sepsis and systemic bacterial infection; (7) refusal to participate in the trial.

Design outcomes

Primary

Measure	Time frame
rate of rebleeding;	—

Secondary

Measure	Time frame
rate of patency;Child-Pugh classification;survival time;incidence of HCC;incidence of HE;	—

Countries

China

Contacts

Public ContactChengwei Tang

shcqcdmed@163.com+86 0 18980601275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026